Core Tech Solutions coretechtransdermal.com


Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to the worlds pharmaceutical companies. In addition to offering research and development on a contractual basis, Core Tech Solutions possesses the facilities and expertise to perform or coordinate all other aspects of commercialization including Feasibi...Show all

Core Tech Solutions, Inc. is engaged in the development of Transdermal, Dermal and Tran mucosal Delivery Systems for the treatment of a variety of indications. The primary mission of the company is to provide transdermal drug delivery development to ...Show all

Company (Alive / Active)

Phone: 609-443-1400

Fax:

50 Lake Drive
East Windsor, 08520
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Core Tech Solutions $0M Nov 30, 2018
See all 29 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Core Tech Solutions Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Pacira Pharmaceuticals

San Diego, California, United States
IPO / Went publicPacira Pharmaceuticals is focused on formulating, developing and manufacturing controlled-release injectable products based on two drug delivery platforms: DepoFoam and Biosphere. Currently the Company is generating revenue with two marketed products: DepoCyt for lymphomatous meningitis and DepoDur for the treatment of post-surgical pain.Login to see details

Taiwan Liposome Company

South San Francisco, California, United States
IPO / Went publicTaiwan Liposome Company (TLC) is a biopharmaceutical company engaging in research, development and commercialization of proprietary drug delivery system for improving the treatment of cancer, ophthalmic conditions, and infectious diseases.Login to see details
See all 29 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Transdermal methods and systems for treating alzheimer's disease Aug 17, 2006 Feb 02, 2016 Patent